Verdence Capital Advisors LLC Astrazeneca PLC Transaction History
Verdence Capital Advisors LLC
- $1.66 Billion
- Q3 2025
A detailed history of Verdence Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 41,502 shares of AZN stock, worth $3.71 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
41,502
Previous 40,283
3.03%
Holding current value
$3.71 Million
Previous $2.81 Million
13.15%
% of portfolio
0.19%
Previous 0.2%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,521Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...